Primary Amyloidosis
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis (NCT02555969) | Tufts Medical Center | 2015-08-01 |
| Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis (NCT01707264) | Prothena Biosciences Ltd. | 2013-04-01 |
| A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis (NCT00883623) | Heidelberg University | 2009-04-01 |
| Radioimmunoimaging of AL Amyloidosis (NCT00807872) | University of Tennessee | 2008-12-01 |
| Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden (NCT00651937) | M.D. Anderson Cancer Center | 2008-03-01 |
Track Primary Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.